1 ANNEX, Regulation (EU) 2019/150

In forcesince 30 Jan 2019

The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:

(1)

Part A is amended as follows:

(a)

the entry for Deltamethrin is replaced by the following:

Active substance | Rapporteur Member State | Co-rapporteur Member State

‘Deltamethrin | AT’ |

(b)

the entry for Diflufenican is replaced by the following:

Active substance | Rapporteur Member State | Co-rapporteur Member State

‘Diflufenican | CZ’ |

(c)

the entry for Fluoxastrobin is replaced by the following:

Active substance | Rapporteur Member State | Co-rapporteur Member State

‘Fluoxastrobin | DE’ |

(d)

the entry for Prothioconazole is replaced by the following:

Active substance | Rapporteur Member State | Co-rapporteur Member State

‘Prothioconazole | PL’ |

(2)

Part B is amended as follows:

(a)

the entry for Epoxiconazole is replaced by the following:

Active substance | Rapporteur Member State | Co-rapporteur Member State

‘Epoxiconazole | PL’ |

(b)

the entry for Tebuconazole is replaced by the following:

Active substance | Rapporteur Member State | Co-rapporteur Member State

‘Tebuconazole | DK’ |